SUMMARY A survey of fasting whole blood amino acids in 65 patients with various subtypes of retinitis pigmentosa was performed. Eight X-linked recessive patients showed decreased taurine and aspartate. Nineteen autosomal recessive patients, and to a lesser extent 10 autosomal dominant patients, showed reduced levels of whole blood threonine and histidine. Branched-chain amino acids and arginine were present in increased amounts in 2 patients with Laurence-Moon-BardetBiedl syndrome. These findings in LMBB patients are probably related in part to their obesity and emphasise that appropriate controls are required, and other factors (including age) known to affect amino acid levels must be accounted for. The biochemical implications of our findings are not yet apparent.
The discovery of the molecular cause of retinal degeneration in a few animal models and the elucidation of an enzymatic deficiency in gyrate atrophy of the retina and choroid with hyperomithinaemia have generated a renewed search for the biochemical causes for human retinitis pigmentosa (RP). To date there have been few indices suggesting the possibility of a metabolic disorder. The problem is made more complex by the inaccessibility of human pathological material and by the clinical complexity and genetic heterogeneity of RP. This is in contrast to the considerable progress achieved in the investigation of the amino acid metabolism in gyrate atrophy,' a related disorder.
The few data available in RP suggesting a metabolic disorder are the following. In a recent Finnish study decreased uptake of taurine by platelets of RP patients of unspecified inheritance patterns when compared with controls was demonstrated. 4 Cats fed a diet deficient in taurine develop a retinal degeneration. 5 However, amino acid data in humans with RP are scarce. Berson et al. have reviewed the subject of amino acids in retinal degenerations and reported on 26 patients with RP.6 No significant differences from normal controls were identified in the fasting plasma levels of 12 amino acids. We report herein a study of 18 fasting whole-blood amino acid levels in 65 
Materials and methods
Patients in this study were referred to the Hospital for Sick Children's Ophthalmic Genetics Clinic either for genetic counselling or for inclusion in the study. Some patients previously examined in the clinic were recalled for participation. Control values were obtained from healthy individuals known to be free of metabolic, ocular, and systemic diseases and matched in so far as possible with the patient population for age and sex.
In order to subclassify the RP patients, where a detailed family history was not already available, each patient was asked to fill out the Hospital for Sick Children's eye genetics questionnaire, a family tree was constructed, and, if necessary and possible, relatives were examined. An appropriate consent was obtained. Each patient was asked to fast from midnight, and the following morning between 9 and 11 am blood was drawn for haematocrit, glucose, insulin, and whole blood amino acid measurements. When the collected data were deemed satisfactory (by criteria detailed below), the patient was entered into the study and assigned to one of the groups (RPG) shown in Table 1 .
The method for amino acid analysis was as follows. The venous blood drawn from the patient was immediately deproteinised by addition to an equal We have confirmed the instability of glutamine after prolonged storage at -20°C and at the pH of the non-neutralised PCA supernatants.' This amino acid spontaneously deamidates to form glutamic acid, causing spuriously raised levels of the latter and decreased levels of the former. The conversion does not occur to a significant degree after neutralisation to a pH of 4-9 (which does not affect the other amino acids) or with immediate analysis of the sample. Because the neutralisation step was introduced after the study began, glutamine and glutamic acid data are presented only for those samples in which valid levels were obtained. Insulin was assayed by radioimmunoassay as previously detailed7 and plasma glucose was determined by the glucose oxidase method with a Beckman glucose analyser (Beckman Instruments Inc., Fullerton, CA). All analyses were performed by technicians who were unaware of whether samples were from patients or controls.
Results from some subjects were excluded on the following criteria: (1) Incomplete genetic history precluding precise assessment of the pattern of inheritance (n= 10). (2) Plasma insulin and glucose levels indicated that the patient had most likely not fasted as requested; such patients were excluded from the study (n=3). (3) A patient suffering from a rare syndrome which had as one of its components RP was excluded (n= 1). (4) found no significant deviations from normal among the 12 amino acids that were studied. Other amino acids were not reported in their study (Table 4) . It is in these previously unreported amino acids that the most significant changes were found in the present study of whole-blood amino acids. Several statistically significant differences have been shown in the present study. How biologically significant are they? Indeed, when comparing 18 amino acids in 7 independent groups one could obtain 5-7 statistically significant results, at the p<005 level, merely by chance. In addition it is apparent from Table 2 that the RP and control populations were not perfectly matched, in that the RP females were older than the control females, while the LMBB patients were the youngest. These differences may cause the groups not to be entirely comparable biochemically. The LMBB patients were significantly heavier than all other groups, but this is an expected part of the syndrome and undoubtedly accounts for some of the observed differences. Elevations in most of the amino acids shown to be increased are expected in obesity in relation to insulin resistance; our subjects showed typical markedly elevated insulin levels.'" Similarly, glycine levels are decreased in obesity and increased in protein malnutrition. Finally, particularly in the LMBB group, the sample is rather small, consisting of only 2 patients. The next smallest subgroup is the Usher's syndrome with 8 patients, which is a much more adequate sample size.
From the methodological standpoint care was taken to assure precision of the results. Not all the amino acid determinations were performed immediately after drawing blood. Storage time has been shown to alter significantly the values of glutamic acid and glutamine.' For this reason the reported data for these amino acids are limited, since only data from *Significant changes in one or another subgroup found in this amino acid in present study. * *Most significant changes present in these amino acids in present study. samples run immediately after drawing blood are reported. The remaining reported amino acids are stable under the storage and assay conditions used. In addition all samples were drawn fasting in mid morning to minimise possible diurnal fluctuations.
Despite these difficulties it is probable that many of these findings represent biologically significant differences, even if only the data that are significant at less than the p<005 level (i.e., <0-01 and <0 001) are considered. Threonine and histidine are moderately reduced in autosomal dominant patients. The branched-chain amino acids valine, isoleucine, and leucine, as well as arginine, were significantly increased at the p<0001 level in the 2 patients with Laurence-Moon-Bardet-Biedl syndrome. The elevations in the branched chain amino acids may be secondary to obesity, but the increase in arginine is unexplained. It is noteworthy that most of the significant alterations reported involve essential amino acids.
How can the present results be interpreted with regard to the cause of the alterations and their relationship to the observed disease? These findings should be interpreted against the background of gyrate atrophy as the prototype metabolic retinal degeneration. This study has confirmed that there is no dramatic alteration in any single amino acid in these RP groups comparable to the extreme elevation of ornithine in gyrate atrophy. It is probable that the changes which we have observed in the RP patients represent secondary alterations, perhaps comparable to the low levels of lysine and glutamic acid seen in gyrate atrophy.' The challenge, therefore, remains to identify one or more primary metabolic defects to which the present observations can be related. It is probable, in view of the heterogeneity of RP, that several such defects might be identified relating to the modes of inheritance. The most provocative speculation would be to relate the lowered taurine levels in X-linked recessive RP to the observations in taurinedeficient cats' and the more recent demonstration of defective taurine uptake by platelets of 12 RP patients, though the inheritance patterns of the disease manifested in the families of these 12 patients were unspecified by the authors.4 It is noteworthy that most of the taurine in the circulation is concentrated within platelets and leucocytes. The failure to demonstrate either larger changes or significant differences in other RP subtypes may relate to this compartmentation. Furthermore, studies reporting only plasma levels of taurine6 might obscure otherwise significant changes by failure to assess its intracellular levels in the formed elements.
The decreased threonine and histidine levels in the autosomal dominant and recessive groups are not readily accounted for. Individual abnormalities in the metabolism of these amino acids have been reported, but as with most aminoacidopathies they are characterised by raised levels. In neither case is an abnormality of the eyes among the typical manifestations.
The significantly lower fasting glucose levels in the males of several of the RP subgroups is unexplained. The present demonstration of higher fasting glucose in normal males than females conforms to a well recognised pattern. All values are within the normally accepted ranges for age, and there are no differences in insulin levels which could account for the glucose values. Indeed, those amino acids most sensitive to ambient insulin levels'0 are not consistently altered in association with the lower glucose levels, so that, if increased insulin sensitivity were postulated, it would have to be specific for glucose. This is unlikely to be the case.
